Torsemide
Who holds supplier records for Torsemide? 17 organisations hold a current record for Torsemide: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 14 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (6), China (2), Italy (2), United States (1) and 4 other countries (4); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Torsemide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/torsemide
Reading the evidence
- 17 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 8 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (17)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Torsemide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 23174 · latest filing Oct 2009
- CAMBREX CHARLES CITY INCUnited StatesCEPActive DMF 17489 · latest filing Jun 2004
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 18360 · latest filing Jun 2007
- Ipca Laboratories LimitedIndiaCEP Company GMP cert on recordActive DMF 23760 · latest filing Sept 2010
- MEDILUX LABORATORIES PVT LTDIndiaCEP Company GMP cert on recordActive DMF 35736 · latest filing Mar 2021
- MICRO LABS LTDIndiaCEP Company GMP cert on recordActive DMF 35901 · latest filing May 2021
- TAPI NL BVNetherlandsCEPActive DMF 15738 · latest filing Nov 2001
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 24549 · latest filing Dec 2010
- JARI PHARMACEUTICAL CO LTDActive DMF 26208, 27406 · latest filing Aug 2013
- KALINTIS HEALTHCARE PVT LTDIndiaActive DMF 36664 · latest filing Jan 2022
- ZHEJIANG DONGDONG PHARMACEUTICAL CO LTDActive DMF 21576 · latest filing Apr 2008
- Arevipharma GmbHGermanyCEP Company GMP cert on recordInactive DMF 25845 · latest filing Feb 2012
- ItalyCEP Company GMP cert on record
- ChinaCEP
- SANOCHEMIA PHARMAZEUTIKA GMBHAustriaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- BIOINDUSTRIA L.I.M. S.P.A.ItalyCEPValid CEP holder (EDQM); not necessarily the manufacturer
- F Hoffmann-La Roche Ltd.SwitzerlandCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (14)
Certificates of Suitability on the EDQM register for Torsemide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 20 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| COSMA S.P.A. Ciserano | IT | CEP 2026-045 - Rev 00 Torasemide, Code 1252, Form-I | Jul 2026 | Inspected Nov 2025 Italy |
| SANOCHEMIA PHARMAZEUTIKA GMBH Neufeld An Der Leitha | AT | CEP 2005-304 - Rev 03 Torasemide | Jun 2026 | Inspected Feb 2025 Austria |
| MICRO LABS LIMITED Bengaluru | IN | CEP 2021-167 - Rev 01 Torasemide | Mar 2026 | — |
| IPCA LABORATORIES LIMITED Mumbai | IN | CEP 2010-278 - Rev 02 Torasemide | Sept 2025 | — |
| HETERO LABS LIMITED Hyderabad | IN | CEP 2019-255 - Rev 02 Torasemide, Form-I | Jul 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2010-299 - Rev 03 Torasemide | Jan 2025 | — |
| AREVIPHARMA GMBH Radebeul | DE | CEP 2024-070 - Rev 00 Torasemide, Process N | Sept 2024 | Inspected Jun 2025 Germany |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | CEP 2009-061 - Rev 05 Torasemide | Jun 2024 | Inspected May 2026 Italy |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2008-059 - Rev 03 Torasemide | Nov 2023 | — |
| MEDILUX LABORATORIES PRIVATE LIMITED Pithampur | IN | R1-CEP 2015-228 - Rev 00 Torasemide | Mar 2022 | — |
| HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO., LTD. Jingmen City | CN | R1-CEP 2006-088 - Rev 02 Torasemide | Apr 2019 | — |
| BIOINDUSTRIA L.I.M. S.P.A. Novi Ligure | IT | R1-CEP 2008-251 - Rev 01 Torasemide | Mar 2018 | — |
| CAMBREX CHARLES CITY, INC. Charles City | US | R1-CEP 2005-111 - Rev 00 Torasemide | Feb 2012 | — |
| F Hoffmann-La Roche Ltd. Basel | CH | R1-CEP 2005-210 - Rev 00 Torasemide | Sept 2011 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (5)
Organisations whose Type II DMFs for Torsemide are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- Micro Labs Ltd IndiaInactive DMF 24687 · filed Nov 2010
- India · Inactive DMF 21954 · filed Oct 2008
- Apotex Pharmachem India Pvt. Ltd.India · Inactive DMF 18466 · filed Jun 2005
- ROCHE DIAGNOSTICS GMBHInactive DMF 16851 · filed Sept 2003
- Teva Pharmaceutical Industries Ltd.Israel · Inactive DMF 15222 · filed Jan 2001
Overview
Torsemide is a pyridine-sulfonylurea type loop diuretic used to treat edema associated with heart failure, renal disease, or hepatic disease. It functions by inhibiting the Na+/K+/2Cl- carrier system (symporter) in the thick ascending limb of the loop of Henle.
Chemical identity
- IUPAC name
- 1-[[4-(3-methylanilino)-3-pyridinyl]sulfonyl]-3-propan-2-ylurea
- Canonical SMILES
- CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
- InChIKey
- NGBFQHCMQULJNZ-UHFFFAOYSA-N
- Synonyms
- Demadex API, ac-4464, ac4464, bm-02.015, bm-02015, bm02.015, luprac, soaanz, torasemide, torasemide anhydrous, upcard
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Loop Diuretic
- Physiologic effect
- Increased Diuresis at Loop of Henle
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Torsemide?
17 organisations hold an active US FDA Type II Drug Master File or a CEP for Torsemide: APITORIA PHARMA PRIVATE LTD (India), CAMBREX CHARLES CITY INC (United States), Hetero Labs Limited (India), Ipca Laboratories Limited (India), MEDILUX LABORATORIES PVT LTD (India), MICRO LABS LTD (India), TAPI NL BV (Netherlands) and Zhejiang Huahai Pharmaceutical Co., Ltd. (China), and 9 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Torsemide Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 23174), CAMBREX CHARLES CITY INC (DMF 17489), Hetero Labs Limited (DMF 18360), Ipca Laboratories Limited (DMF 23760), MEDILUX LABORATORIES PVT LTD (DMF 35736), MICRO LABS LTD (DMF 35901), TAPI NL BV (DMF 15738) and Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 24549) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Torsemide records mean?
5 organisations have only inactive Type II DMFs for Torsemide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Torsemide have a European Certificate of Suitability?
Yes. 14 organisations hold a valid CEP for Torsemide on the EDQM register, including COSMA S.P.A. Ciserano (IT), SANOCHEMIA PHARMAZEUTIKA GMBH Neufeld An Der Leitha (AT), MICRO LABS LIMITED Bengaluru (IN), IPCA LABORATORIES LIMITED Mumbai (IN), HETERO LABS LIMITED Hyderabad (IN) and TAPI NL B.V. Amsterdam (NL) and 8 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Torsemide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Torsemide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.